REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -66.7% | 459 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | -20.8% | 414 | +9.8% | 0.00% | -50.0% |
| Q2 2021 | $53,000 | -76.9% | 377 | -83.6% | 0.00% | -75.0% |
| Q1 2021 | $229,000 | +15.1% | 2,300 | +42.6% | 0.01% | -11.1% |
| Q4 2020 | $199,000 | +95.1% | 1,613 | +146.6% | 0.01% | -18.2% |
| Q2 2020 | $102,000 | +537.5% | 654 | +289.3% | 0.01% | +175.0% |
| Q2 2019 | $16,000 | +700.0% | 168 | +572.0% | 0.00% | +300.0% |
| Q1 2019 | $2,000 | -94.6% | 25 | -94.5% | 0.00% | -92.3% |
| Q3 2018 | $37,000 | +76.2% | 458 | -22.8% | 0.01% | +85.7% |
| Q2 2018 | $21,000 | – | 593 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |